Mitsuo Ohashi is a prominent inventor based in Ohmiya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 7 patents to his name, Ohashi's work has had a meaningful impact on the industry.

Latest Patents

Ohashi's latest patents include innovative compounds such as phenoxyalkylcarboxylic acid derivatives. These compounds are represented by a specific formula where R indicates a hydrogen atom, methyl group, or ethyl group, with m being an integer from 2 to 5, and n an integer from 3 to 8. The compounds also feature X and X, which independently represent a sulfur atom, oxygen atom, sulfinyl group, or sulfonyl group, with the condition that X and X are not simultaneously oxygen atoms. Their alkali salts and hydrates are recognized for their utility as antiallergic agents. Another notable patent involves thiazolidine-2,4-dione derivatives, their salts, and their preparation, showcasing Ohashi's versatility in creating valuable pharmaceutical products.

Career Highlights

Ohashi is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has not only contributed to the company's portfolio but has also enhanced the understanding of various chemical compounds in the pharmaceutical field.

Collaborations

Ohashi has collaborated with esteemed colleagues such as Katsuya Awano and Toshio Tanaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mitsuo Ohashi stands out as a key figure in pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions through patents and collaborations reflect his commitment to advancing the field of pharmaceutical chemistry.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]